How XRAY’s Performance Has Shaken Out over the Last Month

Dentsply’s price performance

Dentsply Sirona (XRAY) stock witnessed a steady uptick in November, rising from $34.58 on November 6 to $37.78 on November 30. In the last few trading sessions, Dentsply Sirona stock has seen selling pressure. It corrected to $36.81 on December 4.

Despite the price gains seen by Dentsply stock in the past month, it’s still off its January 4 high of $68.30.

How XRAY’s Performance Has Shaken Out over the Last Month

Financial snapshot

Dentsply Sirona’s top line fell 7.69% from $1.01 billion in the third quarter of 2017 to $931.6 million in the third quarter of 2018. The company’s revenue in the fourth quarter of 2018 is expected to be $1.03 billion, a year-over-year fall of 6.1%.

Its gross margin contracted from 58.57% in the third quarter of 2017 to 54.97% in the third quarter of 2018. Dentsply’s 2018 and 2019 gross margins are expected to be 55.04% and 55.3%, respectively.

From $1.57 billion in 2017, Dentsply’s net loss is expected to narrow to $1.03 billion in 2018. The company is expected to generate a net income of $313.46 million in 2019.

Analysts’ recommendations

In December, of the total 15 analysts covering Dentsply Sirona, five have given the stock “buy” or higher ratings, and ten have given it “hold” ratings. While the mean rating for Dentsply remains unchanged from November at 2.53, its target price has been lowered to $46.73 in December compared to $47.6 in November.

In the next article, we’ll explore the price performance of Illumina.